average monthly weight loss on glp 1 GLP-1 medications are changing the landscape of obesity treatment, but having realistic expectations is really important. Clinical trials showed weight loss of approximately: • ~15% body weight with semaglutide • ~ How Much Weight Can I

GLP-1 receptor agonists are a class of medications originally developed and licensed for the treatment of type 2 diabetes mellitus, with some formulations also approved by the MHRA for weight management in adults with obesity or overweight with weight-related comorbidities, under specialist services as per NICE guidance (TA875)

For instance, Wegovy injections, which contain a higher dose of semaglutide than Ozempic, are specifically FDA-approved for chronic weight management in adults and adolescents with obesity or overweight with at least one weight-related condition [7] [8]

Among the observations from microdosing patients, some have reported non-scale changes they attribute to reduced inflammation

a small study compared dapagliflozin and teneligliptin in patients with MASLD and found improvements in transaminases and a reduction in body fat only in the group treated with dapagliflozin 49

Concerning IBS, including its constipation-predominant variant (IBS-C), the aggregate benefit derived from probiotic supplementation is typically marginal (392)